Chronic myelogenous leukemia in a child following treatment for bilateral retinoblastoma

Haitham Hilal Al Mahrouqi, Anuradha Ganesh, Abdulhakim Al Rawas, Vikas Khetan, Sana Al Zuhaibi

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)


A 3-year-old child was incidentally found to have chronic myelogenous leukemia (CML) during an admission for a routine ophthalmic examination under anesthesia. The child had received systemic chemotherapy and focal treatment for Groups C and D retinoblastoma in the right and left eye, respectively, when she was 7 months old. CML was treated with dasatinib, and the child attained a major molecular response. The child is now 3 years after treatment of CML, and the retinoblastoma remains inactive. CML following treatment of retinoblastoma is a rare occurrence. Long term and close monitoring of retinoblastoma patients who received systemic chemotherapy using serial blood tests is essential.

Original languageEnglish
Pages (from-to)187-189
Number of pages3
JournalOman Journal of Ophthalmology
Issue number3
Publication statusPublished - Sept 1 2021
Externally publishedYes


  • Chemotherapy
  • chronic myelogenous leukemia
  • retinoblastoma

ASJC Scopus subject areas

  • Ophthalmology


Dive into the research topics of 'Chronic myelogenous leukemia in a child following treatment for bilateral retinoblastoma'. Together they form a unique fingerprint.

Cite this